Zacks Research Predicts Neogen’s Q3 Earnings (NASDAQ:NEOG)

Neogen Co. (NASDAQ:NEOG) – Investment analysts at Zacks Research reduced their Q3 2025 earnings per share (EPS) estimates for Neogen in a report released on Wednesday, February 12th. Zacks Research analyst R. Department now anticipates that the company will earn $0.11 per share for the quarter, down from their previous forecast of $0.12. The consensus estimate for Neogen’s current full-year earnings is $0.38 per share.

Neogen (NASDAQ:NEOG) last issued its quarterly earnings results on Friday, January 10th. The company reported $0.11 EPS for the quarter, beating the consensus estimate of ($0.01) by $0.12. Neogen had a positive return on equity of 2.89% and a negative net margin of 52.12%. The firm had revenue of $231.30 million during the quarter, compared to analysts’ expectations of $227.16 million. During the same period in the prior year, the firm posted $0.11 earnings per share. The business’s quarterly revenue was up .7% compared to the same quarter last year.

Other research analysts have also recently issued reports about the company. Guggenheim initiated coverage on Neogen in a research report on Thursday, December 19th. They set a “buy” rating and a $15.00 price target for the company. Piper Sandler reissued a “neutral” rating and set a $13.00 price target (down from $16.50) on shares of Neogen in a research report on Tuesday, January 21st.

Neogen Stock Performance

Shares of NASDAQ NEOG opened at $10.39 on Monday. The stock has a 50 day moving average price of $11.66 and a 200 day moving average price of $14.08. Neogen has a 52 week low of $9.70 and a 52 week high of $18.58. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.46 and a current ratio of 3.77. The stock has a market capitalization of $2.25 billion, a PE ratio of -4.74 and a beta of 1.23.

Institutional Trading of Neogen

Several institutional investors and hedge funds have recently bought and sold shares of the business. Allspring Global Investments Holdings LLC increased its stake in shares of Neogen by 142.6% during the third quarter. Allspring Global Investments Holdings LLC now owns 1,982 shares of the company’s stock worth $33,000 after purchasing an additional 1,165 shares during the period. Harbour Investments Inc. bought a new position in shares of Neogen during the fourth quarter worth approximately $27,000. Blue Trust Inc. increased its stake in shares of Neogen by 196.7% during the fourth quarter. Blue Trust Inc. now owns 3,368 shares of the company’s stock worth $41,000 after purchasing an additional 2,233 shares during the period. Johnson Financial Group Inc. bought a new position in shares of Neogen during the fourth quarter worth approximately $43,000. Finally, Neo Ivy Capital Management bought a new position in shares of Neogen during the third quarter worth approximately $66,000. Institutional investors own 96.73% of the company’s stock.

Insider Buying and Selling at Neogen

In other Neogen news, CEO John Edward Adent acquired 23,035 shares of the company’s stock in a transaction on Thursday, January 16th. The shares were purchased at an average price of $11.03 per share, for a total transaction of $254,076.05. Following the completion of the purchase, the chief executive officer now directly owns 269,164 shares of the company’s stock, valued at approximately $2,968,878.92. This represents a 9.36 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO David H. Naemura acquired 14,800 shares of the company’s stock in a transaction on Thursday, January 16th. The stock was acquired at an average price of $11.11 per share, for a total transaction of $164,428.00. Following the purchase, the chief financial officer now directly owns 61,434 shares of the company’s stock, valued at approximately $682,531.74. This trade represents a 31.74 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 1.13% of the company’s stock.

About Neogen

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.